Rocket Pharmaceuticals Inc（RCKT）價格預測RCKTRocket Pharmaceuticals Inc

Alphio's RCKT stock price prediction model matches the current Rocket Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.65 (+1.50%). The 1-week path is $2.25 (-13.97%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Rocket Pharmaceuticals Inc appears to be a good buy right now due to its recent upgrade by Needham to a Buy rating with a price target of $9, suggesting a potential upside of approximately 150% from the current price of $2.47. Additionally, the stock has shown a positive momentum with a 5-day change of +8.33%, indicating increasing investor interest. The main risk to consider is the company's forward P/E ratio, which is currently at 0, reflecting uncertainty in future earnings projections.

Rocket Pharmaceuticals Inc (RCKT) last closed at $2.6099999, gaining +3.98%. These facts feed the 1-day and 1-week RCKT price prediction above.